Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002036 · ClinicalTrials.gov registry record · Phase 1
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00002036 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 12 participants.
The verdict
NCT00002036, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.
Interventions
- DRUG Anti-HIV Immune Serum Globulin (Human)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002036
The ClinicalTrials.gov registry entry for NCT00002036 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anti-HIV Immune Serum Globulin (Human) is the first listed.
NCT00002036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002036 about?
NCT00002036 is a clinical study titled "Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)". To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.
What is the current status of trial NCT00002036?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants.
What interventions are being tested in trial NCT00002036?
The interventions under investigation include: Anti-HIV Immune Serum Globulin (Human) (DRUG).
Who is sponsoring clinical trial NCT00002036?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.